Acadia Healthcare Company, Inc. (ACHC) 2018 Q3 法說會逐字稿

完整原文

使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主

  • Operator

    Operator

  • As a reminder, this call is being recorded. Please proceed.

    提醒各位,本次電話會議正在錄音。請繼續。

  • William Brent Turner - President

    William Brent Turner - President

  • Good morning. I'm Brent Turner, President of Acadia Healthcare, and I'd like to welcome you to our Third Quarter 2018 Conference Call.

    早安。我是 Acadia Healthcare 總裁 Brent Turner,歡迎各位參加我們 2018 年第三季電話法說會。

  • To the extent any non-GAAP financial measure is discussed in today's call, you will also find a reconciliation of that measure to the most directly comparable financial measure calculated according to GAAP on our website by viewing yesterday's news release under the Investors link.

    若今日電話會議中討論任何非 GAAP 財務衡量指標,您也可在我們網站的「投資人」連結下,查看昨日新聞稿以取得該指標與依 GAAP 計算之最直接可比財務衡量指標的調節表。

  • This conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements, among others, regarding Acadia's expected quarterly and annual financial performance for 2018 and beyond.

    本次電話會議可能包含《1995 年私人證券訴訟改革法》所定義的前瞻性陳述,其中包括但不限於關於 Acadia 對 2018 年及其後預期之季度與年度財務表現的陳述。

  • For this purpose, any statements made during the call that are not statements of historical facts may be deemed to be forward-looking statements. Without limiting the foregoing, the words believes, anticipates, plans, expects and similar expressions are intended to identify forward-looking statements.

    就此而言,本次電話會議中任何非歷史事實之陳述,均可能被視為前瞻性陳述。在不限制前述內容之前提下,「相信」、「預期」、「計畫」、「期望」及類似用語旨在辨識前瞻性陳述。

  • You are hereby cautioned that these statements may be affected by the important factors, among others, set forth in Acadia's filings with the Securities and Exchange Commission and in the company's third quarter news release. And consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements. The company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

    特此提醒您,這些陳述可能受到多項重要因素影響(其中包括 Acadia 向美國證券交易委員會提交之文件及公司第三季新聞稿中所載因素)。因此,實際營運與結果可能與前瞻性陳述中討論之結果存在重大差異。公司不承擔公開更新任何前瞻性陳述之義務,無論係因新資訊、未來事件或其他原因。

  • At this time, for opening remarks, I'll now turn the call over to our Chairman and Chief Executive Officer, Joey Jacobs.

    現在進入開場致詞,我將把電話交給我們的董事長兼執行長 Joey Jacobs。

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Good morning, and thank you for being with us today for our third quarter conference call. In addition to Brent, I'm here today with our Chief Financial Officer, David Duckworth, and other members of our executive management team. David and I each have some remarks about the third quarter and our outlook for going forward in 2018, then we will open the line for your questions.

    早安,感謝各位今天參加我們的第三季電話會議。除了 Brent 之外,今天與我一同出席的還有我們的財務長 David Duckworth,以及其他執行管理團隊成員。David 和我將分別就第三季表現及 2018 年後續展望發表一些看法,之後我們將開放提問。

  • Acadia produced solid growth of 6.2% in revenue for the third quarter. Our revenue growth continues to be driven primarily by organic growth, including a 6.2% increase in total same facility for the quarter. This increase was mainly the result of adding 806 beds to our operations over the last 12 months. We added 132 beds during the third quarter and 408 in the first 9 months of this -- of the year, and we expect to add more than 800 beds to existing and new facilities in 2018.

    Acadia 第三季營收穩健成長 6.2%。我們的營收成長仍主要由內生成長所驅動,包括本季同院所(same facility)總計成長 6.2%。此增幅主要來自過去 12 個月我們營運中新增 806 張床位。第三季我們新增 132 張床位,年初至今前 9 個月新增 408 張床位;我們預期 2018 年在既有與新設院所合計新增超過 800 張床位。

  • Our 6.2% total same-facility revenue growth included a 2.4% increase in patient days and a 3.8% increase in revenue per patient day. U.S. same-facility revenue increased 7.2% for the quarter with a 3.3% increase in patient days and a 3.8% increase in revenue per patient day. U.S. same facility EBITDA margin increased 60 basis points to 27.4%.

    我們同院所(same-facility)營收總成長 6.2%,其中包含病患日(patient days)增加 2.4%,以及每病患日營收(revenue per patient day)增加 3.8%。美國同院所營收本季增加 7.2%,其中病患日增加 3.3%,每病患日營收增加 3.8%。美國同院所 EBITDA 利潤率提升 60 個基點至 27.4%。

  • Core operations in the U.K., same facility revenue was up 4.4%, consisting of 1.3% increase in patient days and a 3.1% increase in revenue per patient day. Same facility EBITDA margin declined 450 basis points to 16.9% for the quarter. Our operations in the U.K. were affected by a lower census and higher-than-expected operating expenses. Our operating costs were significantly higher, primarily due to the ongoing nursing and clinical staff shortage and our dependence on higher-cost agency labor. The census in our existing health care business declined as we experienced a decrease in referrals from the NHS.

    在英國的核心營運方面,同院所營收成長 4.4%,其中病患日增加 1.3%,每病患日營收增加 3.1%。本季同院所 EBITDA 利潤率下滑 450 個基點至 16.9%。我們在英國的營運受到入住量(census)較低及營運費用高於預期的影響。營運成本顯著上升,主要因護理與臨床人員持續短缺,以及我們對成本較高的派遣人力(agency labor)的依賴。由於我們經歷來自 NHS 的轉介減少,既有醫療照護業務的入住量有所下降。

  • Similar to industry trends, we continue to experience difficulty with recruiting nurses and clinical staff, which requires us to utilize agency labor to fill those positions. Because their census did not reach a sufficient level to absorb the higher wages and other operating costs, our third quarter margins and earnings were adversely affected. We expect continued difficulties resulting from the nursing and clinical staff shorter -- shortage for the foreseeable future.

    與產業趨勢相同,我們持續面臨招募護理與臨床人員的困難,因此必須使用派遣人力來補足這些職缺。由於入住量未達足以吸收較高薪資及其他營運成本的水準,我們第三季的利潤率與獲利受到不利影響。我們預期在可預見的未來,護理與臨床人員短缺仍將持續帶來困難。

  • We signed definitive agreements for 2 acquisitions following the end of the third quarter, one with Mission Treatment, which operates 9 comprehensive treatment centers for substance abuse with locations in California, Nevada, Arizona and Oklahoma. We also announced an agreement to acquire The Whittier Pavilion, a 71-bed inpatient psychiatric hospital in Haverhill, Massachusetts.

    在第三季結束後,我們簽署了兩項收購的最終協議,其中一項為 Mission Treatment,該公司在加州、內華達州、亞利桑那州與奧克拉荷馬州營運 9 家針對物質濫用的綜合治療中心。我們也宣布達成協議,將收購位於麻薩諸塞州哈弗希爾(Haverhill)的 The Whittier Pavilion,一家擁有 71 張床位的住院精神科醫院。

  • Thanks for your time this morning and your interest in Acadia. Now here's David Duckworth to discuss our financial results and guidance in more detail.

    感謝各位今天早上的時間以及對 Acadia 的關注。接下來請 David Duckworth 更詳細說明我們的財務結果與財測指引。

  • David M. Duckworth - CFO, CAO & Controller

    David M. Duckworth - CFO, CAO & Controller

  • Thanks, Joey, and good morning. The company's revenue for the third quarter of 2018 was $760.9 million, an increase of 6.2% from $716.7 million for the third quarter of 2017. Adjusted earnings per diluted share were $0.55 for the third quarter of 2018 compared with $0.58 for the third quarter last year. Adjusted EPS excludes transaction-related expenses of $2.4 million for the third quarter of 2018 and $5.7 million for the third quarter of 2017.

    謝謝你,Joey,早安。公司 2018 年第三季營收為 7.609 億美元,較 2017 年第三季的 7.167 億美元成長 6.2%。2018 年第三季調整後稀釋每股盈餘為 0.55 美元,去年同期為 0.58 美元。調整後 EPS 排除 2018 年第三季 240 萬美元及 2017 年第三季 570 萬美元的交易相關費用。

  • The company's consolidated adjusted EBITDA for the third quarter of 2018 was $148.9 million or 19.6% of revenue. Acadia's operating cash flows from continuing operations were $288.7 million for the 9 months ended September 30, 2018, compared with $272.6 million for the same period last year.

    公司 2018 年第三季合併調整後 EBITDA 為 1.489 億美元,占營收 19.6%。截至 2018 年 9 月 30 日止 9 個月,Acadia 持續營運之營業活動現金流量為 2.887 億美元,去年同期為 2.726 億美元。

  • Turning to our financial guidance. And as announced in yesterday's news release, we have adjusted our 2018 financial guidance based on the company's performance for the first 9 months of the year and our expectations for the fourth quarter.

    接著談我們的財測指引。如昨日新聞稿所宣布,我們已根據公司今年前 9 個月的表現以及對第四季的預期,調整 2018 年財務指引。

  • Our full year guidance is as follows: revenue of approximately $3 billion, adjusted EBITDA in a range of $605 million to $610 million and adjusted diluted EPS in the range of $2.25 to $2.27.

    我們的全年指引如下:營收約 30 億美元;調整後 EBITDA 介於 6.05 億至 6.10 億美元;調整後稀釋 EPS 介於 2.25 至 2.27 美元。

  • This concludes our prepared remarks this morning, and I'll now turn it over to Joey for some final comments.

    以上為我們今天早上預先準備的發言內容,接下來我將交回給 Joey 做最後補充。

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Thank you, David. Before we move into Q&A, I want to briefly address the recent press reports and rumors regarding Acadia being approached by private equity firms. It is our company's policy not to comment on rumors or speculation. That's all we will say today on this topic, so we ask that you keep your questions focused on our results.

    謝謝你,David。在進入問答之前,我想簡要回應近期媒體報導與傳聞,內容涉及 Acadia 可能曾被私募股權公司接觸。本公司政策是不對傳聞或臆測發表評論。今天我們對此議題就說到這裡,因此也請各位將問題聚焦在我們的業績表現。

  • I will now ask Kathy to open the floor for your questions.

    現在我將請 Kathy 開放各位提問。

  • Operator

    Operator

  • (Operator Instructions) And we'll go first to A.J. Rice of Crédit Suisse.

    (接線員指示) 我們先請 Crédit Suisse 的 A.J. Rice 提問。

  • Albert J. William Rice - Research Analyst

    Albert J. William Rice - Research Analyst

  • Maybe 2 questions, if I could. First of all, there's also been some reporting -- particularly mainly in the financial press this quarter about regulatory issues that maybe the company's been facing. And I wanted to give you a chance to give any comments you'd like to give about that and then also to ask you in the aftermath because it didn't seem to get picked up in the popular press. I would think there hasn't been any change in your interaction with regulators, but just to ask whether that is indeed the case.

    也許我可以問兩個問題。首先,本季也有一些報導——特別主要是在金融媒體——提到公司可能面臨一些監管議題。我想給您一個機會,就此發表任何您想說的評論,另外也想在事後追問一下,因為這似乎沒有被大眾媒體廣泛報導。我認為你們與監管機構的互動應該沒有任何改變,但想確認是否確實如此。

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Sure, A.J. Referring to the statement I've made in previous earnings calls concerning regulatory issues at a few of our facilities, I'm pleased to announce that all of those have been resolved and that those facilities do not have admission holds as of this time. As you know, A.J., we're a large company with a large number of facilities. So at any time -- and at any time, we can have an inspection go bad or an incident occur or an investigation be instigated. So -- but I'm pleased to report that for the ones we've been talking about this year, those facilities have their admission holds removed and have their license and are building back their census.

    當然,A.J。就我在先前幾次財報電話會議中提到的、我們少數幾家機構所面臨的監管議題而言,我很高興宣布,這些問題都已經解決,而且截至目前,這些機構都沒有收治限制(admission holds)。如你所知,A.J.,我們是一家大型公司,旗下有大量機構。因此在任何時候——任何時候——都可能遇到一次稽查結果不理想、或發生事件、或啟動調查。所以——但我很高興可以回報,今年我們一直在談的那些機構,已解除收治限制、也已取得執照,並正在把入住人數(census)逐步拉回來。

  • Albert J. William Rice - Research Analyst

    Albert J. William Rice - Research Analyst

  • Okay, all right. And the other question I was going to ask was obviously about the U.K. operations. It sounds like the issues that you're experiencing are really more the margin, not really anything you'd say with respect to your management team over there not doing what they should be doing. I want to confirm that, that is indeed what you think. And then you sort of said in your prepared remarks that this is -- potentially could go on for a while. Does it make you think about capital allocation to the U.K. differently? Does it make you think about repositioning that portfolio somehow? I don't know what the options are. But give us some flavor for, okay, if this does persist, what can you do to try to at least minimize the impact on Acadia overall, given that the U.S. operations still seem to be doing pretty well?

    好的,了解。我另一個想問的問題,顯然是關於英國(U.K.)的營運。聽起來你們遇到的問題主要是利潤率(margin),而不是你會說英國那邊的管理團隊沒有把該做的事做好。我想確認一下,這確實是你們的看法。另外你在事先準備的發言中也提到,這——可能會持續一段時間。這會讓你們以不同方式看待對英國的資本配置嗎?會讓你們考慮以某種方式重新定位那個投資組合嗎?我不確定有哪些選項。但請給我們一些方向:如果這種情況持續,你們能做些什麼,至少把對 Acadia 整體的影響降到最低,畢竟美國(U.S.)的營運看起來仍然表現得相當不錯?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Sure, A.J. First, in the U.K., Absolutely, the nurse shortage continues and actually grows. So we see that occurring, continuing and going forward. So that's the reason for the lowering the guidance. We do expect to, hopefully, rebound on the census, to grow the census however small it might be, but we do have beds coming online that the NHS wanted us to retool so that we could take those patients. However, unfortunately, when we get those patients, a part of that staffing will be nurse agency costs, but it would still be incremental positive to us. So as far as capital deployment to the U.K., we have a pretty stringent policy, whether it's in the U.K., in the U.S. now about capital deployment. But it will be a little bit tougher for capital to be deployed in the U.K. We are seeing a lot of activity here in the U.S. for the use of our capital. So as -- so we'll just take that a day at a time. But yes, we will be more careful about deploying capital to the U.K.

    當然,A.J。首先,在英國,護理人力短缺確實仍在持續,甚至還在加劇。所以我們看到這個情況正在發生、會持續並延續到未來。這也是我們下修財測指引的原因。我們確實希望入住人數(census)能回升,並讓入住人數成長——即使幅度可能不大——但我們確實有一些床位即將啟用,這些床位是 NHS 希望我們重新調整配置(retool),以便我們能收治那些病患。然而,不幸的是,當我們收治這些病患時,部分人力配置將會是護理派遣(nurse agency)成本,但對我們而言仍會帶來增量的正面貢獻。至於在英國的資本投放,我們不論在英國或現在在美國,對資本投放都有相當嚴格的政策。但在英國,資本投放會稍微更困難一些。我們看到在美國這邊有很多資本使用的機會。所以——所以我們會一天一天地評估。但沒錯,我們會更謹慎地把資本投放到英國。

  • Operator

    Operator

  • Our next question will come from Kevin Fischbeck of Bank of America Merrill Lynch.

    下一個問題來自美國銀行美林(Bank of America Merrill Lynch)的 Kevin Fischbeck。

  • Kevin Mark Fischbeck - MD in Equity Research

    Kevin Mark Fischbeck - MD in Equity Research

  • Great. So I guess, given some of those comments, do you think that the kind of the margin profile that you showed this quarter in the U.K. is the right way to think about it, at least for the next several quarters?

    很好。所以我想,基於剛才的一些評論,你認為本季英國所呈現的那種利潤率(margin)輪廓,是不是至少在接下來幾季應該用來看待的正確方式?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Well, Kevin, I think that is the profile for the next quarter for sure. Could it go a little bit lower? Yes. But the team is working on making it, growing it. So -- but it is tough all across U.K. for health care providers concerning just nurse and clinical staff shortage. So that does continue to put pressure on us and everybody. So -- but our goal would be to improve the margin, and we would have to get there through growing the census incremental to the census, I think.

    Kevin,我認為至少下一季肯定會是那樣的輪廓。會不會再低一點?會的。但團隊正在努力讓它改善、讓它成長。所以——但英國各地的醫療服務提供者都面臨艱難處境,主要就是護理與臨床人員短缺。因此這確實持續對我們以及所有人造成壓力。所以——但我們的目標是改善利潤率,而我認為我們必須透過提升入住人數(census),在既有入住人數之上取得增量成長,才能達成。

  • Kevin Mark Fischbeck - MD in Equity Research

    Kevin Mark Fischbeck - MD in Equity Research

  • Okay. Then I guess to that end, can you talk a little bit about what happened? You said that census was lower because the NHS had a decrease in referral, but you also talked about them asking you to take -- to add more beds. So can you talk about what happened in the quarter, why that was an issue and how long it takes to fix itself?

    好的。那我想順著這點,你能否多談一下發生了什麼?你說入住人數較低是因為 NHS 的轉介(referral)減少,但你也提到他們要求你們收治——增加更多床位。所以你能談談本季發生了什麼、為什麼會成為問題,以及需要多久才能自行修復嗎?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Well, in this quarter, those are the holiday months over in the U.K. and we should have been more pessimistic in our budget for what the census would do. And yes, during the year, the NHS has come to us and asked us to build beds for certain services, and those beds are coming online. And so both of those things occurred. The census was softer, but the NHS is asking us to build beds to meet the needs of the patients in the U.K.

    嗯,在這一季,英國那邊正好是假期月份,我們在預算上對入住人數(census)的走勢應該要更悲觀一些。而且沒錯,在今年期間,NHS 來找我們,要求我們為某些服務增建床位,而這些床位正在陸續啟用。所以這兩件事同時發生。入住人數較疲弱,但 NHS 也要求我們增建床位,以滿足英國病患的需求。

  • Kevin Mark Fischbeck - MD in Equity Research

    Kevin Mark Fischbeck - MD in Equity Research

  • Okay. So when do those kind of new referrals start to kick in?

    好的。那這類新的轉介大概什麼時候開始顯現?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • We already have some of the new referrals now, and we expect that to grow. But that does -- Kevin, I can't predict. Does the existing base census soften a little? I hope it doesn't. I want it to grow. Everybody in the U.K. wants it to grow, and that's what we're focused on. But we'll just have to wait and see. And -- but we're predicting more of the same for the fourth quarter that we saw in the third quarter.

    我們現在已經有一些新的轉介了,而且我們預期會成長。但那確實——Kevin,我無法預測。既有的基礎入住人數(base census)會不會稍微走弱?我希望不會。我希望它成長。英國的每個人都希望它成長,而這也是我們專注的方向。但我們只能再觀察看看。而且——我們對第四季的預期,是大致延續第三季所看到的情況。

  • Kevin Mark Fischbeck - MD in Equity Research

    Kevin Mark Fischbeck - MD in Equity Research

  • Okay. And this may be last question because, like, 4.5% same-store growth is actually not a bad number. But obviously, given the labor pressures, you need a higher number. What number do you think you need to get to on a same-store basis in the U.K. to be able to maintain margins?

    好的。這可能是最後一個問題,因為像 4.5% 的同店成長其實不是個差的數字。但顯然在勞動力壓力之下,你們需要更高的數字。你認為在英國,以同店(same-store)基礎來看,需要達到什麼樣的成長率才能維持利潤率?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Well, we know 4% won't do it. So we're -- Kevin, quite frankly, we're going to have to have some relief on the premiums we're having to pay for the nurse agencies. There's got to be more staff, more nurses, more clinicians enter into the system. And we are, actually, I think, might -- going through this environment the best of any of the providers. The NHS, they have the worst of the problem. They have, I think, thousands of open positions for nurses. So that has to be fixed. We can grow the census and marginally improve the margin in earnings, hopefully, but it's really the souring wages. That's the issue.

    嗯,我們知道 4% 不夠。所以——Kevin,坦白說,我們必須在目前不得不支付給護理派遣機構(nurse agencies)的溢價上,獲得一些緩解。系統裡必須有更多人力、更多護理師、更多臨床人員加入。而且我認為,實際上,我們在所有提供者之中,可能是把這個環境應對得最好的。NHS 的問題最嚴重。他們我想有數千個護理師職缺。所以這必須被解決。我們可以透過提升入住人數(census),在獲利上小幅改善利潤率,希望如此,但真正的問題是薪資飆升。那才是問題所在。

  • Operator

    Operator

  • We will now take a question from Matt Borsch of BMO Capital Markets.

    我們現在將接聽來自 BMO Capital Markets 的 Matt Borsch 的提問。

  • Matthew Richard Borsch - Managed Care and Providers Analyst

    Matthew Richard Borsch - Managed Care and Providers Analyst

  • Yes. Just a little bit more on the U.K. Can you just talk about your level of commitment to the U.K. as a market, given these results as you look into 2019? I mean, I guess, one of the questions here, in addition to the unfavorable developments and the uncertainty of Brexit impact, is given that they're an ocean away, does that impact your ability, top management's ability to be on top of trends in this close away as you are in the U.S.?

    是的。再多談一點英國。鑑於這些結果、展望 2019 年,能否談談你們對英國作為一個市場的承諾程度?我的意思是,我想這裡其中一個問題,除了不利的發展以及對英國脫歐影響的不確定性之外,還有就是既然隔著海洋,這是否會影響你們的能力——高層管理團隊是否能像在美國那樣,緊貼那邊的趨勢?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • We have a medcert, we have a psych hospital 40 minutes from us here in the corporate office. So I can keep an eye on that facility basically from my office. But the U.K. distance really is not an issue. They keep us up-to-date, and we have enough detail to know what's happening over there. So a 17% EBITDA margin, that's okay. It's not what we expect, but that's a pretty good margin. And as Kevin mentioned earlier, more than a 4% revenue growth, that would be a strong number here in the U.S. So we have some positive numbers, and we're just weathering the storm and doing everything we can on the expense side to make a stronger asset today than we had yesterday.

    我們有一個 medcert,我們在公司總部這裡 40 分鐘車程有一家精神科醫院。所以我基本上可以在辦公室就掌握那家機構的情況。但英國的距離其實不是問題。他們會讓我們隨時掌握最新狀況,我們也有足夠的細節了解那邊正在發生什麼。所以 17% 的 EBITDA 利潤率,這還可以。這不是我們所期望的,但這是相當不錯的利潤率。而且如 Kevin 先前提到的,超過 4% 的營收成長,在美國這裡也會是一個很強的數字。所以我們有一些正面的數據,我們只是挺過風暴,並在費用端盡一切努力,讓今天的資產比昨天更強。

  • Matthew Richard Borsch - Managed Care and Providers Analyst

    Matthew Richard Borsch - Managed Care and Providers Analyst

  • Got it, got it. It makes sense. Has anything changed with respect to what you had talked about last quarter in terms of -- last quarter, you talked about the ability to bring in labor from the Commonwealth countries and how that was something that was helping. Has the situation changed? Or is just that it's just tougher than you had hoped it would be for the second half?

    了解,了解。這很合理。就你們上季談到的部分,有沒有任何改變——上季你們談到能從英聯邦國家引進勞動力,而那一直是有幫助的。情況有改變嗎?還是只是下半年比你們原本希望的更艱難?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • It's just tougher. It is just tougher. And the government -- yes, it is tougher. Thank you.

    只是更艱難。就是更艱難。而政府——是的,就是更艱難。謝謝。

  • Operator

    Operator

  • And next, we've got Peter Costa of Wells Fargo Securities.

    接下來是 Wells Fargo Securities 的 Peter Costa。

  • Peter Heinz Costa - MD and Senior Analyst

    Peter Heinz Costa - MD and Senior Analyst

  • Back to the same area, a couple questions. Let's start with the slowdown in NHS referrals to you. Do you believe those referrals are going somewhere else? Do you believe the 2 competitors? Is there the ability to stay with NHS beds? Or is it just less demand?

    回到同一個領域,有幾個問題。先從 NHS 轉介給你們的量放緩談起。你認為那些轉介是流向別處了嗎?你認為是流向那兩個競爭對手嗎?是否有能力維持 NHS 床位?還是只是需求變少?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • I don't think they're going to competitors. NHS may be keeping them longer in the system before they get to us. But quite frankly, just getting them through the system and getting them funded is the speed of the referrals. And once again, during the third quarter, it slows down historically, and it did this time, too. So we hope that the referrals will pick up in pace because everybody's back, but we're getting ready to head into the holidays. So we're trying to be a little bit conservative about that, too. And we hope that the funding of the individual patient will happen at a quicker pace. So those are things we're working on and talking to the referral sources over in the U.K.

    我不認為他們流向競爭對手。NHS 可能在把病人轉到我們這裡之前,會在體系內留得更久。但坦白說,讓他們走完流程並取得資金核准,才是影響轉介速度的關鍵。而且再一次,第三季歷來就會放慢,這次也一樣。所以我們希望轉介速度會回升,因為大家都回來了,但我們也正準備進入假期。因此我們也試著在這方面保守一些。我們也希望單一病患的資金核准能更快。所以這些都是我們正在努力、並與英國那邊的轉介來源溝通的事項。

  • Peter Heinz Costa - MD and Senior Analyst

    Peter Heinz Costa - MD and Senior Analyst

  • Okay. Then second question. The talk of your company being taken private has been more recent than the talk of you, perhaps, selling the U.K. assets, which has been some time ago. Did that talk ever filtrate down into the management of the U.K. facilities or, perhaps, to the NHS in terms of impacting their referral streams to you such that, that conversation or that talk impacted your business?

    好的。第二個問題。關於你們公司可能私有化的討論,比你們可能出售英國資產的討論更近期;後者其實已經談了一段時間。這些討論是否曾向下影響到英國機構的管理層,或可能影響到 NHS,進而影響他們對你們的轉介量,使得這些對話或傳聞影響了你們的業務?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • I do not think so. No one has brought that to my attention.

    我不這麼認為。沒有人向我提過這件事。

  • Peter Heinz Costa - MD and Senior Analyst

    Peter Heinz Costa - MD and Senior Analyst

  • Okay. And then lastly, can you give us some concrete things about what you're doing to improve the margins going forward here? For example, if you don't have the business, you could consolidate facilities, perhaps. So is there some mechanism that you can talk about the concrete steps of how you're going to fix things?

    好的。最後,能否具體談談你們接下來要做哪些事情來改善利潤率?例如,如果沒有業務量,你們可能會整併機構,或許。所以是否有一些機制可以談談你們將如何以具體步驟來把狀況修正?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Yes. We're -- we have more than 500 facilities there. We're looking at the lower number of performing facilities and what we can do with them. And worst-case scenario, it would be that we would close them and that we're not adverse to doing that. Or if we decided we could put 20 facilities together and maybe somebody would want them or whatever, we would look at that, too. But primarily, if we can't turn around the lower-performing facilities, then we will make the decision to close them.

    是的。我們——我們在那邊有超過 500 家機構。我們正在檢視表現較差的機構,以及我們能對它們做什麼。最壞的情況是我們會關閉它們,而我們並不排斥這麼做。或者如果我們決定把 20 家機構整合在一起,也許有人會想要收購之類的,我們也會評估。但主要是,如果我們無法扭轉那些表現較差的機構,那我們就會做出關閉的決定。

  • Peter Heinz Costa - MD and Senior Analyst

    Peter Heinz Costa - MD and Senior Analyst

  • Do you have a number as to how many of those lower-performing facilities are on that target list?

    你們有沒有一個數字,說目標清單上大概有多少家表現較差的機構?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • We're going through that process right now.

    我們現在正在進行那個流程。

  • Operator

    Operator

  • And now our question will come from Brian Tanquilut from Jefferies.

    接下來的提問來自 Jefferies 的 Brian Tanquilut。

  • Brian Gil Tanquilut - Equity Analyst

    Brian Gil Tanquilut - Equity Analyst

  • Joey, just sorry to go back to the U.K., but what changed?

    Joey,不好意思又回到英國,但到底改變了什麼?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • No, U.K., U.K. -- Brian, you can't go back to the U.K. Let's talk about the U.S.

    不,英國、英國——Brian,你不能再回到英國了。我們來談談美國。

  • Brian Gil Tanquilut - Equity Analyst

    Brian Gil Tanquilut - Equity Analyst

  • I will not.

    我不要。

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Let's talk about it. It's 7%.

    我們來談吧。是 7%。

  • Brian Gil Tanquilut - Equity Analyst

    Brian Gil Tanquilut - Equity Analyst

  • No, that will be one question. But just really quickly in the U.K. The big drop in margins, we saw challenges in Q3 of last year, and your margins dropped to 21%. But the 450 basis point drop just seemed really big, and it seems like the last few quarters, you had your eye on the ball really closely on staffing. So what blindsided you here in the quarter?

    不,那會是一個問題。但很快地回到英國。利潤率大幅下滑,我們看到去年第三季也有挑戰,你們的利潤率降到 21%。但這次下滑 450 個基點看起來真的很大,而且看起來過去幾季你們一直很密切關注人力配置。所以這一季到底是什麼讓你們措手不及?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • The census was softer than our expectation. And then we had to use -- our discussions with the U.K. operators, we had to use more nurse agency expense just on the base patient. And then on the new beds that we opened up that we utilized more nurse agency expense there. And the census, it takes a little while for that census to ramp up. I think we'll be fine once it ramps up. It will cover the additional costs of the agency nurse. But those are the 2 things that hit us in the third quarter was a softening of the census, but more importantly, the nurse agency just was too great.

    入住人數(census)比我們預期更疲弱。然後我們必須使用——根據我們與英國營運團隊的討論,我們在既有病患基礎上就必須使用更多護理派遣(agency nurse)費用。而且在我們新開的床位上,我們也更多使用護理派遣費用。而入住人數需要一點時間才能爬升。我認為一旦爬升起來就會沒問題。它將能覆蓋派遣護理人員的額外成本。但第三季打擊我們的兩件事是:入住人數走弱,但更重要的是,護理派遣費用實在太高了。

  • Brian Gil Tanquilut - Equity Analyst

    Brian Gil Tanquilut - Equity Analyst

  • Got it. And then, all right, I'll shift to the U.S. business now. So pretty good same-store this quarter. How are you thinking about your ability to maintain or ratchet up that same-store volume trend, number one? And then, how are you thinking about potential facility closures in 2019 or any impact from news reports that it seems like you're exiting some markets here in the U.S.?

    了解。好,那我現在轉到美國業務。這一季同店表現相當不錯。第一,你們如何看待維持或進一步提升同店量能趨勢的能力?第二,你們如何看待 2019 年可能的機構關閉,或新聞報導提到你們似乎正在退出美國某些市場,這是否會帶來任何影響?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Say that one more time, Brian.

    再說一次,Brian。

  • Brian Gil Tanquilut - Equity Analyst

    Brian Gil Tanquilut - Equity Analyst

  • So yes. So your same-store volumes are stronger this quarter. So how do you think about the sustainability of that or your ability to ratchet that up? And then the follow-up is just I think there are reports that you're exiting some markets in the U.S. Just want to hear your thoughts on that and how that impacts 2019.

    所以是的。所以你們本季同店量(same-store volumes)更強。那你怎麼看其可持續性,或你們將其再往上拉升的能力?另外一個追問是,我想有報導說你們正在退出美國的一些市場。想聽聽你對此的看法,以及這對2019年的影響。

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Sure, absolutely. First, absolutely, the key to this is building the beds. And we've got those beds coming online, and we've got a group of de novo facilities and joint venture facilities that will be going into the same-store, in addition to the beds that we have built at those facilities. So it is good to see that it looks like the U.S. census wants to grow same-store facility, wants to grow more than 3%. And you saw that in the third quarter, and I think that is a goal for us, is to get more than 3%, closer to the 4%. So as your comment about ratcheting up, I think the potential for us to grow the census higher here does exist. Now the only thing I'm aware of that we might be closing or we are closing is we have an out-patient business in a state that we made a decision to close that due to the state not reimbursing us, and they had cut reimbursement. So it didn't make the business model work, and we reviewed that. And so we are closing those out-patient services in that state, and it was the right decision to do.

    當然,絕對可以。首先,這裡的關鍵絕對是把床位建起來。而這些床位正在陸續啟用,我們也有一批新設(de novo)機構與合資機構,除了我們在那些機構已建成的床位之外,這些也將納入同店(same-store)。所以很高興看到,美國的入住人數(census)看起來希望推動同店機構成長,且希望成長超過3%。你在第三季也看到了,我認為這也是我們的目標:超過3%,更接近4%。所以就你提到的再往上拉升,我認為我們確實存在把入住人數進一步提高的潛力。至於我唯一知道我們可能會關閉、或正在關閉的,是我們在某一州的門診(out-patient)業務;我們決定關閉,原因是該州不再給我們報銷,且他們下調了報銷標準。因此商業模式無法成立,我們也做了檢視。所以我們正在關閉該州的門診服務,我們認為這是正確的決定。

  • Operator

    Operator

  • Our next question will come from Frank Morgan of RBC Capital Markets.

    下一個問題來自RBC Capital Markets的Frank Morgan。

  • Frank George Morgan - MD of Healthcare Services Equity Research

    Frank George Morgan - MD of Healthcare Services Equity Research

  • I kind of want to go back to that last question in a little more detail. Obviously, when we start thinking about 2019, from what you're saying about the U.K., we don't -- correct me if I'm wrong, but I don't think we should expect a lot of improvement there. So my question is in terms of how you can compensate for that in your U.S. operations, either through margin expansion on your consolidated base today but also, perhaps, even acquisitions. So if you could kind of give us a little color on, perhaps, how you could offset some of the lack of growth in the U.K., how you could accelerate growth in the U.S. to maintain a higher overall growth enterprise. And then, specifically, maybe you even comment a little bit about these acquisitions you've announced today.

    我想更詳細地回到上一個問題。顯然,當我們開始思考2019年時,從你對英國(U.K.)的說法來看,我們不——如果我說錯請糾正——但我認為我們不應該期待那邊有太多改善。所以我的問題是,就你們如何在美國業務中補償這一點而言,可能透過你們目前合併基礎上的利潤率擴張,但也可能透過併購。所以如果你能提供一些補充說明,例如你們如何抵消英國成長不足、以及如何在美國加速成長以維持整體企業較高的成長。另外,或許你也能具體評論一下你們今天宣布的這些併購。

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Sure, Frank. The key to here in the U.S. is to increase our occupancy and fill the beds we're building. They're absolutely in the same-store numbers that will drive that. And secondly, those facilities that A.J. talked about that had regulatory issues this year, if we can keep that to a minimum, that was me knocking on wood. If we can keep that to a minimum, that will improve the margin. So we have an opportunity here that if we'll execute and have a little good luck, that we can grow the census and actually improve the margin here in the U.S. on the same-facility basis. So that is one way we can help offset some of the U.K. And then as far as the acquisitions, we have been analyzing these acquisitions probably for the last 5 months, and you probably have heard me mention it on the call that we would be making some acquisitions this year. And we like the facility up in Massachusetts, the acute hospital. As you know, we have one of our large joint ventures in Massachusetts, and we have quite a bit of penetration on the CTC side in Massachusetts. And then the Mission acquisition, the CTC acquisition. This is a single owner that had started this business several years ago, had grown it and was wanting to start planning for his retirement. And we were fortunate in that the team was able to negotiate this -- that transaction also. So we think they both fit us very well in existing businesses and markets. So good acquisitions. Frank, are you still there?

    好的,Frank。在美國這裡的關鍵是提高入住率,把我們正在建的床位填滿。這些絕對會反映在同店數據中並推動成長。第二,A.J.提到的那些今年遇到監管問題的機構,如果我們能把這種情況降到最低——我這是在敲木頭求個好兆頭。如果能把它降到最低,就會改善利潤率。所以我們在這裡有一個機會:如果我們能執行到位,再加上一點好運,我們就能在美國以同店基礎提升入住人數,並且實際改善利潤率。這是我們用來部分抵消英國影響的一種方式。至於併購,我們大概在過去5個月一直在分析這些併購,你可能也聽我在電話會議上提過,我們今年會做一些併購。我們喜歡麻薩諸塞州(Massachusetts)那家機構,也就是那家急性期醫院(acute hospital)。如你所知,我們在麻薩諸塞州有一個大型合資企業,而且我們在麻薩諸塞州的CTC業務也有相當高的滲透率。另外是Mission的收購,也就是CTC的收購。這是一位單一業主,幾年前創立了這項業務,把它做大,並希望開始規劃退休。我們很幸運,團隊也成功談成了這筆交易。所以我們認為這兩項都非常符合我們在既有業務與市場中的布局。所以是很好的併購。Frank,你還在線上嗎?

  • Frank George Morgan - MD of Healthcare Services Equity Research

    Frank George Morgan - MD of Healthcare Services Equity Research

  • I'm sorry. Yes. In terms of just the sort of embedded growth potential in your U.S. operations from when you've had these issues and you could fill them up, do you have a number on, like, how many beds we're talking about that will be available for -- if we were trying to get to a number on how much EBITDA growth potential there is from any of these underutilized beds?

    抱歉。是的。就你們美國業務中那種內嵌的成長潛力而言,當你們之前有這些問題、而你們可以把床位填滿時,你們有沒有一個數字,例如我們在談的是多少床位可供使用——如果我們想估算這些未充分利用床位所帶來的EBITDA成長潛力有多少?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • I don't have that number, Frank. I'm sure, in our analysis, working on this project, we have that. We're getting ready to do this. We're in the process of doing the 2019 budgets. So I would be able to speak more about that in the first quarter about what the assumptions are for that in 2019.

    我沒有那個數字,Frank。我確定在我們針對這個專案所做的分析裡,我們是有的。我們正準備要做這件事。我們正在編製2019年的預算。所以我會在第一季更能談這件事,以及2019年相關假設是什麼。

  • Frank George Morgan - MD of Healthcare Services Equity Research

    Frank George Morgan - MD of Healthcare Services Equity Research

  • Okay. One last one. Do you think '19 would be a year where you would make more acquisitions? Would you accelerate the pace of acquisitions in '19? Or is there going to be sort of a retrench in the U.K. and fill up what you got in the U.S.?

    好的。最後一個問題。你認為2019年會是你們進行更多併購的一年嗎?你們會在2019年加快併購步伐嗎?還是英國那邊會有某種收縮,並先把美國現有的資產填滿?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Adequate -- I mean, carefully deploying our capital, which means more of it will be going to the U.S., and we will make acquisitions next year. The number is still not -- we haven't pegged a number. We'll just take them one at a time, the opportunities. We have several joint ventures that we're looking at. So we'll just take it one at a time.

    適度——我的意思是,謹慎地部署我們的資本,這意味著更多資本會投向美國,而且我們明年會進行併購。數量目前還沒有——我們還沒定出一個數字。我們會一次看一個機會。我們正在評估幾個合資案。所以我們就一次處理一個。

  • Operator

    Operator

  • And we'll go now to Ana Gupte of Leerink Partners.

    接下來我們轉到Leerink Partners的Ana Gupte。

  • Anagha A. Gupte - MD of Healthcare Services & Senior Research Analyst

    Anagha A. Gupte - MD of Healthcare Services & Senior Research Analyst

  • You have -- so in the U.S., the volumes look great, the patient -- the revenue per patient day also looks really good. And wanted to understand what the underlying drivers were. Is it a mix issue around acute residential or payer mix or more psych versus addiction? And what's the sustainability of that going into '19?

    你們——所以在美國,量看起來很棒,每病人日收入(revenue per patient day)看起來也非常好。我想了解背後的驅動因素是什麼。是急性期住宿(acute residential)的組合問題、或付款方組合(payer mix)、或是精神科(psych)相對於成癮治療(addiction)的占比變化嗎?而這在進入2019年時的可持續性如何?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • I'm going to let David take this question.

    我讓David來回答這個問題。

  • David M. Duckworth - CFO, CAO & Controller

    David M. Duckworth - CFO, CAO & Controller

  • Yes. Ana, the key driver in the revenue per day is payer increases from our different payers, and we've seen increases for Medicaid, commercial Medicare really across all payer categories this year. That is the key driver. As you know, we have added more acute beds so that, that would be a small part of the growth would be the acute mix becoming stronger. But the key driver is rate increases.

    好的。Ana,每日收入的關鍵驅動因素是我們不同付款方的支付上調(payer increases),而且我們今年在Medicaid、商業保險、Medicare等方面,幾乎在所有付款方類別都看到了上調。這是關鍵驅動因素。如你所知,我們新增了更多急性期床位,因此急性期組合變得更強,會是成長中的一小部分。但關鍵驅動因素是費率上調(rate increases)。

  • Anagha A. Gupte - MD of Healthcare Services & Senior Research Analyst

    Anagha A. Gupte - MD of Healthcare Services & Senior Research Analyst

  • Okay. So underlying rate increases. Got it. On the -- then on the length of stay, you've had a little bit of pressure here. It's obviously been offset by the volumes, and so you get good patient day growth. One of your peers has talked about this managed Medicaid mix shifting for a while, and they continue to talk about that this quarter. Is that likely to accelerate for you? Or is your book of business pretty much are you kind of reaching a place where the length of stay pressures have reached a floor?

    好的。所以基礎費率上調。了解。再來談到住院天數(住院期間),你們這裡確實有一點壓力。顯然已被量的成長所抵消,因此病人日數成長不錯。你們的一位同業談到受管制的醫療補助(managed Medicaid)組合轉移已經一段時間了,而且本季仍在談這件事。這對你們來說有可能加速嗎?還是說你們的業務組合基本上——你們是否已經接近一個住院天數壓力觸底的狀態?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Ana, this is Joey. The length of stay is very stable. The length of stay for acute patients is 9 days this year versus last year for this quarter, and it was 9 days. The specialty is 21 days this year versus 21 days last year. And the RTC is basically the same as it was last year. What's driving it down is -- or mathematically, what does this is the lower length of stay on more of the acute patients. So our length of stay is not an issue internally.

    Ana,我是Joey。住院天數非常穩定。急性病患的住院天數今年本季是9天,去年同季也是9天。專科(specialty)今年是21天,去年也是21天。而RTC基本上也和去年一樣。真正把它往下拉的——或從數學上來看造成這個結果的是:更多急性病患的住院天數較短。所以我們內部來看,住院天數不是問題。

  • Anagha A. Gupte - MD of Healthcare Services & Senior Research Analyst

    Anagha A. Gupte - MD of Healthcare Services & Senior Research Analyst

  • All right. It's not an issue for you. Okay. Yes, I mean, it's very modest this time around compared to your volumes anyways. And then the last one was on the labor on the U.S. side. Again, you've had very good success recruiting. Your markets are not the same as UHS. They did have some wage inflation pressure, and I think they also talked about competition from new entrants or maybe it's private companies or PE investing. It was hard to understand, really. But is there anything that might suggest that going forward in the U.S. too, there'll be wage pressure that should impact your margins? Or are you comfortable on that one ?

    好。對你們來說不是問題。好的。是的,我的意思是,跟你們的量相比,這次其實非常溫和。最後一個問題是美國端的勞動力。同樣地,你們在招募方面做得很成功。你們的市場和UHS不一樣。他們確實面臨一些薪資通膨壓力,我想他們也提到來自新進者的競爭,或許是民營公司或私募股權(PE)投資。老實說有點難理解。但未來在美國端,有沒有任何跡象顯示薪資壓力也會影響你們的利潤率?還是你們對這點很有把握?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Ana, we feel pretty comfortable. We think we're going to be able to live with a 2% to 3% raise in wages next year as we go through our merit increases. There are -- there will be and has been. There'll be a few isolated markets where we might have to do something different in those markets just because of not being able to fund the -- all staff we need. And we address those as one-offs. And so that's how we'll approach 2019. So we feel good about the position that we're in but once again, we have different markets, that's right. And we probably have more rural markets. So -- but we're okay. We'll do 2% to 3% in our budget for next year and hope to stay within that.

    Ana,我們覺得相當有把握。我們認為明年在進行績效調薪時,能夠承受2%到3%的薪資調升。確實會有——也一直都有。會有少數零星市場,我們可能必須在那些市場採取不同作法,因為無法補足我們所需的全部人力。我們會把那些當作個案處理。因此我們會用這種方式來面對2019年。所以我們對目前的處境感覺良好,但再一次,我們的市場確實不同。而且我們可能有更多偏鄉市場。所以——但我們沒問題。明年的預算我們會編列2%到3%,並希望能控制在這個範圍內。

  • Operator

    Operator

  • We will take our next question from John Ransom of Raymond James.

    接下來我們將接聽Raymond James的John Ransom的提問。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • Let's just say, hypothetically, that the team decides so maybe the better part of valor is to look at maybe see if there's a buyer out there for U.K. and refocus on the U.S. Do you have any market feedback as to what kind of multiple assets are trading for over there?

    假設一下,假如團隊決定也許更審慎的做法是看看英國業務是否有買家,並把重心重新放回美國。你們是否有任何市場回饋,了解那邊資產大概以什麼倍數在交易?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • John, I'm going to pull out the no-comment answer.

    John,我要用「不予評論」的回答。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • I had to try. The other thing, you used to give an agency labor percentage number, latter part of last year, early part of this year. Obviously, that number has gone up. But can you give us a ballpark range of how much that's up versus a year ago?

    我得試試看。另外一件事,你們在去年後半、今年前半曾提供過一個派遣人力(agency labor)占比的數字。顯然那個數字已經上升了。但你們能否給我們一個大概的區間,說明相較一年前上升了多少?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • David will give that to you.

    David會提供給你。

  • David M. Duckworth - CFO, CAO & Controller

    David M. Duckworth - CFO, CAO & Controller

  • Yes, John, we have seen, as mentioned, higher agency labor as a percentage of our total labor costs. That's 14% in the third quarter this year compared to just under 12% last year. And total labor cost as a percentage of revenue, 68.5% this quarter, and we were at 65% last year.

    是的,John,如同先前提到的,我們看到派遣人力占總人力成本的比例提高。今年第三季是14%,去年是略低於12%。而總人力成本占營收的比例,本季為68.5%,去年是65%。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • So David, what's the rule of thumb every 1%? Is it the double the cost? Or is it something like that? What's the rule of thumb?

    所以David,經驗法則是每增加1%會怎樣?成本會變成兩倍嗎?還是類似那樣?你們的經驗法則是什麼?

  • David M. Duckworth - CFO, CAO & Controller

    David M. Duckworth - CFO, CAO & Controller

  • For every 1% of the contract increase.

    每增加1%的合約(contract)占比。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • I'm sorry. I think you cut out there.

    抱歉。我想你剛剛那段斷訊了。

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • We're having to pay a 30% premium to the agency per nursing hour on average.

    我們平均每個護理工時需要向派遣機構支付約30%的溢價。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • Got you. And then lastly, switching to the U.S. How should we think about, over the next 3 or 4 quarters, how new beds in the U.S. will come online?

    了解。最後,切換到美國端。未來3到4個季度,美國新增床位將如何陸續開出,我們應該怎麼看?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Similar to how they've done this year, I think. I don't have that schedule with me. David will be glad to give that to you off-line, John, but I think it's going to be similar to this year.

    我想會和今年的做法類似。我手邊沒有那個時程表。David很樂意在會後再提供給你,John,但我認為會和今年差不多。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • And do you have an estimate -- are the startup losses from de novo -- not bed adds, but brand-new facilities, does that ever hit a -- will that hit a point of materiality next year? Or is it just something you can absorb?

    你們有沒有估計——新設(de novo)帶來的開辦虧損——不是新增床位,而是全新設施——明年會不會達到顯著程度?還是只是你們可以吸收的程度?

  • David M. Duckworth - CFO, CAO & Controller

    David M. Duckworth - CFO, CAO & Controller

  • John, this is David. I think as we think about next year, we have had several de novos over the last 12 months. We had 4 different facilities incurring losses, and we do see that continuing just as we have other projects coming online next year. But I do think as these 4 projects and new facilities mature, it would be potentially less of a loss number as we think about 2019 than it has been in 2018.

    John,我是David。我們在思考明年時,過去12個月我們有幾個新設案(de novo)。我們有4個不同的機構正在產生虧損,而明年隨著其他專案陸續上線,我們也預期這種情況會持續。但我確實認為,隨著這4個專案與新設施逐漸成熟,2019年的虧損金額相較2018年可能會更少。

  • John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

    John Wilson Ransom - MD, Equity Research and Director of Healthcare Research

  • What's your number for '18 approximately?

    你們對2018年的數字大概是多少?

  • David M. Duckworth - CFO, CAO & Controller

    David M. Duckworth - CFO, CAO & Controller

  • Well, for the full year, there is approximately $7 million of losses from that group of facilities.

    嗯,以全年來看,這一組機構的虧損大約是700萬美元。

  • Operator

    Operator

  • We will now go to Gary Taylor of JPMorgan.

    接下來我們將轉到JPMorgan的Gary Taylor。

  • Gary Paul Taylor - Analyst

    Gary Paul Taylor - Analyst

  • Most of my questions are answered. Just 2 left. Did I hear you guys talk about the DSO growth and the cause of that? Did I miss that?

    我的大部分問題都已經被回答了。只剩兩個。我有聽到你們談到DSO增加以及其原因嗎?我是不是漏聽了?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • I couldn't hear you.

    我聽不清楚你說什麼。

  • David M. Duckworth - CFO, CAO & Controller

    David M. Duckworth - CFO, CAO & Controller

  • Gary, this is David. The DSO growth, part of it is the de novo facilities that we have. We have seen our DSOs increase from 40 in the first part of this year to 42. Part of that is the de novos, and that's just timing. We should see that return. Part of it is just as we look at the calendar, the month of September, we did have just timing of payments that we expect to improve in the fourth quarter as well. So it's timing between collections in the month of September and then the working capital being built up for our de novo facilities.

    Gary,我是David。DSO的增加,部分原因是我們的新設機構(de novo)。我們看到DSO從今年前段的40天增加到42天。其中一部分是新設案,這只是時間點的問題。我們應該會看到它回落。另外一部分是我們看日曆,9月確實有付款時間點的因素,我們預期第四季也會改善。所以這是9月收款時間點,以及為新設機構建立營運資金所造成的時間差。

  • Gary Paul Taylor - Analyst

    Gary Paul Taylor - Analyst

  • Got it. And then just my second question. I don't recall if you've yet talked about bed growth guidance for 2019. But I'm asking the question in the context of planned capital spending. Obviously, there's been a lot of de novo bed growth, bed adds that have driven CapEx. You guys have been spending probably roughly 75% of your cash from ops on CapEx over the last several years. When you look at the trajectory of CapEx over the next couple, does that large majority of cash from ops invested in the CapEx, does that continue to be the case? Or do you see an opportunity to bring CapEx down and free cash flow up?

    了解。接著是我的第二個問題。我不記得你們是否已經談過 2019 年床位成長的指引。但我是以已規劃的資本支出為背景來問這個問題。顯然,新增設點(de novo)帶來了大量床位成長與新增床位,進而推動了資本支出。過去幾年你們大概把營運現金流的約 75% 用在資本支出上。當你們看未來幾年的資本支出走勢時,營運現金流中有很大一部分投入資本支出,這種情況是否會持續?或者你們是否看到有機會降低資本支出、提高自由現金流?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • I think, Gary, with the opportunities we have to grow the company and to be in supermarkets with these joint ventures and de novos, that we'll continue to do that next year, that if you're doing some modeling or whatever. So I think our CapEx spend will stay about the same. And I think we'll build somewhere hopefully between 700 to 800 beds just based on the number of de novos that we get finalized for the year. So that's our thoughts right now. Now we'll be able to give you a better number at the end-of-the-year call because we'll have our budgets done and the initial capital allocations made.

    Gary,我認為,基於我們成長公司的機會,以及透過這些合資與新增設點(de novo)進入超市型場域,我們明年會繼續這麼做;如果你在做一些模型推估之類的。所以我認為我們的資本支出會大致維持不變。而且我想我們希望能建置大約 700 到 800 張床位,主要取決於我們在年度內最終敲定的新增設點數量。這就是我們目前的想法。不過在年底的電話會議上我們可以給你更好的數字,因為到時我們會完成預算並做出初步的資本配置。

  • Operator

    Operator

  • We will now take a question from Ralph Giacobbe of Citi.

    接下來我們將接聽花旗(Citi)Ralph Giacobbe 的提問。

  • Ralph Giacobbe - Director

    Ralph Giacobbe - Director

  • Just a couple of quick ones for me as well. I wanted to ask about length of stay in the U.K. Obviously, admissions are down, but length of stay was up. It's a little bit of a different dynamic. Maybe just if this is, you think, kind of a one-off quarter. Just want to get off any details on that and if there's anything to sort of call out there.

    我這邊也有幾個很快的問題。我想問一下英國的住院天數(length of stay)。顯然入院人次下降,但住院天數上升。這是有點不同的動態。想請教你們是否認為這可能只是單一季度的偶發情況。也想了解是否有任何細節或需要特別指出的地方。

  • William Brent Turner - President

    William Brent Turner - President

  • Ralph, this is Brent. It's really just a mix of the patients there. I mean, we're not seeing any trends within each of the service lines similar to the U.S. as far as a change over last year. But just given the mix of patients across the different service lines, that's really what's extended the length of stay. And also, it appears when you have a little lighter admission activity, just mathematically, you're going to have higher ALOS.

    Ralph,我是 Brent。這主要就是病患組合的因素。也就是說,就各服務線而言,我們沒有看到像美國那樣、相較去年出現變化的趨勢。但由於不同服務線之間的病患組合變化,這才真正拉長了住院天數。另外,看起來當入院量稍微偏低時,從數學上來說,你的平均住院天數(ALOS)就會更高。

  • Ralph Giacobbe - Director

    Ralph Giacobbe - Director

  • All right. Fair enough. And then I want to go back to the question earlier. I think, in the past, you had talked about potential -- I think it was regulatory relief around Brexit and the ability to bring in offshore staff. So where does that stand? Did that just kind of go away? Or is that still in the works? Is there any specific sort of timing that you can provide around where that stands?

    好。可以理解。接著我想回到先前的問題。我記得過去你們曾談到一個可能性——我想是與脫歐(Brexit)相關的監管鬆綁,以及引進海外員工的能力。所以目前進展如何?那件事是就這樣不了了之了嗎?還是仍在推進中?你能否就目前狀態提供任何較具體的時間點?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Well, they have made the change where we can now get staff from the Commonwealth countries, but that is becoming harder than we initially talked. And also, there is a unique requirement in the U.K. that you have site certification if you are a nurse. And maybe some of the Commonwealth countries do not have that same requirement in their teaching. So if we've got them here, we would have to educate them, get them educated. And then it appears that the government there actually canceled that course. So it's made it tougher for us.

    嗯,他們已經做了變更,現在我們可以從英聯邦國家招募員工,但這件事變得比我們一開始談到的更困難。此外,英國有一項特殊要求:如果你是護理師,必須具備場址認證(site certification)。而英聯邦的一些國家在其培訓中可能沒有同樣的要求。所以如果我們把他們帶到這裡,就必須再教育他們、讓他們完成相關訓練。但看起來當地政府其實取消了那個課程。因此對我們來說更具挑戰。

  • Ralph Giacobbe - Director

    Ralph Giacobbe - Director

  • Okay, all right. And then lastly for me in the U.K. Is there any way to break down and just give a sense whether it's 10% of the facilities that are driving 80% of the pressures? Or is it really broad-based and we shouldn't think of a smaller subset that's driving disproportionate pressure in the U.K.?

    好的,了解。最後一個關於英國的問題:有沒有辦法拆解一下,讓我們了解是否是 10% 的機構造成了 80% 的壓力?還是說壓力其實是全面性的,我們不應該把它想成是由一小部分機構帶來不成比例的壓力?

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Well, I think on the nurse agency, that's the one I could give you the best on. The nurse agency expense is probably being -- the vast majority of that expense is being driven by 10 large -- 10 facilities.

    嗯,我想就護理派遣(nurse agency)這一塊,我可以給你最明確的說法。護理派遣費用——其中絕大多數的費用——大概是由 10 家大型——10 個機構所驅動。

  • Operator

    Operator

  • And with that, that does conclude today's question-and-answer session. I would like to turn things back to Joey Jacobs for any additional or closing comments.

    至此,今天的問答環節就結束了。我想把時間交回給 Joey Jacobs,請他做任何補充或結語。

  • Joey A. Jacobs - Chairman & CEO

    Joey A. Jacobs - Chairman & CEO

  • Thank you, Kathy. Thanks again being with us today and for your interest in Acadia Healthcare. If you have any additional questions today, please do not hesitate to contact us directly and have a good day.

    謝謝你,Kathy。再次感謝各位今天與我們同在,也感謝各位對 Acadia Healthcare 的關注。如果各位今天還有任何其他問題,請隨時直接與我們聯繫,祝各位有美好的一天。

  • Operator

    Operator

  • And again, ladies and gentlemen, that does conclude today's call. We thank you again for your participation. You may now disconnect.

    再次提醒各位女士先生,今天的電話會議到此結束。再次感謝各位的參與。各位現在可以掛線。